1,477 results on '"Slotman, Ben"'
Search Results
52. Is accurate contouring of salivary and swallowing structures necessary to spare them in head and neck VMAT plans?
53. Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017
54. ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer
55. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma
56. Stereotactic Radiosurgery in the Management of Brain Metastases: A Case-Based Radiosurgery Society (RSS) Practice Guideline
57. Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
58. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells
59. Dose distribution prediction for head-and-neck cancer radiotherapy using a generative adversarial network: influence of input data
60. An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report
61. Radiosurgery for epilepsy: Systematic review and International Stereotactic Radiosurgery Society (ISRS) practice guideline
62. Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT
63. Using a knowledge-based planning solution to select patients for proton therapy
64. Stereotactic Ablative Body Radiotherapy for Lung Metastases: Where is the Evidence and What are We Doing With It?
65. Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm
66. Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial
67. Verifying tumor position during stereotactic body radiation therapy delivery using (limited-arc) cone beam computed tomography imaging
68. Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer
69. A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities
70. 1616: Clinical experience with free-breathing expiration-gated 10MV FFF VMAT lung SBRT
71. 962: Preoperative MR-guided single-dose partial breast irradiation: the ABLATIVE-2 trial (NCT05350722)
72. 388: CBCT-guided online adaptive radiotherapy in breast cancer patients – a prospective trial NL2021.0624
73. 380: Clinical experience with same-day delivery of adaptive palliative radiotherapy without a planning CT
74. The relationship of study and authorship characteristics on trial sponsorship and self-reported conflicts of interest among neuro-oncology clinical trials
75. Spine SBRT without immobilization: detailed analysis of intra-fraction motion using high frequency kV imaging during irradiation
76. Isotoxic radiosurgery planning for brain metastases
77. Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with “Ultracentral” Non–Small Cell Lung Cancer
78. Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis
79. Prophylactic cranial irradiation for patients with lung cancer
80. A longitudinal evaluation of improvements in radiotherapy treatment plan quality for head and neck cancer patients
81. Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
82. Treatment and survival of second primary early-stage lung cancer, following treatment of head and neck cancer in the Netherlands
83. Delivery Techniques
84. Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach
85. Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
86. Stereotactic Body Radiotherapy for Lung Oligo-metastases: Systematic Review and International Stereotactic Radiosurgery Society Practice Guidelines
87. Deep learning‐based markerless lung tumor tracking in stereotactic radiotherapy using Siamese networks
88. Impact of imperfection in medical imaging data on deep learning‐based segmentation performance: An experimental study using synthesized data
89. Data from Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma
90. Supplemental Figures 1-7 and Tables 1-2 from Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma
91. Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation
92. Stereotactic ablative radiotherapy (SABR) for central lung tumors: Plan quality and long-term clinical outcomes
93. Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy
94. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
95. Sub-millimeter spine position monitoring for stereotactic body radiotherapy using offline digital tomosynthesis
96. Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials
97. The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future
98. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
99. Normal Tissue Constraints
100. Primary Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.